Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Receivables: 2014-2024

Historic Change in Receivables for Agios Pharmaceuticals (AGIO) over the last 7 years, with Dec 2024 value amounting to $1.3 million.

  • Agios Pharmaceuticals' Change in Receivables rose 106.68% to $43,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 1.60%. This contributed to the annual value of $1.3 million for FY2024, which is 115.07% up from last year.
  • As of FY2024, Agios Pharmaceuticals' Change in Receivables stood at $1.3 million, which was up 115.07% from $604,000 recorded in FY2023.
  • Agios Pharmaceuticals' 5-year Change in Receivables high stood at $2.2 million for FY2022, and its period low was $604,000 during FY2023.
  • Over the past 3 years, Agios Pharmaceuticals' median Change in Receivables value was $1.3 million (recorded in 2024), while the average stood at $1.4 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first plummeted by 72.62% in 2023, then spiked by 115.07% in 2024.
  • Over the past 3 years, Agios Pharmaceuticals' Change in Receivables (Yearly) stood at $2.2 million in 2022, then plummeted by 72.62% to $604,000 in 2023, then skyrocketed by 115.07% to $1.3 million in 2024.